407 related articles for article (PubMed ID: 33990412)
21. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
22. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
[TBL] [Abstract][Full Text] [Related]
23. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
[TBL] [Abstract][Full Text] [Related]
24. Arrhythmogenic Cardiomyopathy.
Corrado D; Basso C; Judge DP
Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
[TBL] [Abstract][Full Text] [Related]
25. Predicting Sudden Cardiac Death in Genetic Heart Disease.
Cadrin-Tourigny J; Tadros R
Can J Cardiol; 2022 Apr; 38(4):479-490. PubMed ID: 35108574
[TBL] [Abstract][Full Text] [Related]
26. Management of arrhythmogenic right ventricular cardiomyopathy.
Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
[TBL] [Abstract][Full Text] [Related]
27. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
Gasperetti A; Carrick RT; Costa S; Compagnucci P; Bosman LP; Chivulescu M; Tichnell C; Murray B; Tandri H; Tadros R; Rivard L; van den Berg MP; Zeppenfeld K; Wilde AAM; Pompilio G; Carbucicchio C; Dello Russo A; Casella M; Svensson A; Brunckhorst CB; van Tintelen JP; Platonov PG; Haugaa KH; Duru F; Te Riele ASJM; Khairy P; Tondo C; Calkins H; James CA; Saguner AM; Cadrin-Tourigny J
Circulation; 2022 Nov; 146(19):1434-1443. PubMed ID: 36205131
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
29. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
[TBL] [Abstract][Full Text] [Related]
30. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
[TBL] [Abstract][Full Text] [Related]
31. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy.
Bosman LP; Nielsen Gerlach CL; Cadrin-Tourigny J; Orgeron G; Tichnell C; Murray B; Bourfiss M; van der Heijden JF; Yap SC; Zeppenfeld K; van den Berg MP; Wilde AAM; Asselbergs FW; Tandri H; Calkins H; van Tintelen JP; James CA; Te Riele ASJM
Europace; 2022 Feb; 24(2):296-305. PubMed ID: 34468736
[TBL] [Abstract][Full Text] [Related]
32. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
[TBL] [Abstract][Full Text] [Related]
33. Detection of gene mutation in the prognosis of a patient with arrhythmogenic right ventricular cardiomyopathy: a case report.
Phan DP; Tran TV; Le VK; Nguyen TV
J Med Case Rep; 2024 Feb; 18(1):49. PubMed ID: 38336791
[TBL] [Abstract][Full Text] [Related]
34. Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort.
Olivetti NQS; Sacilotto L; Wulkan F; D'Arezzo Pessente G; Lombardi Peres de Carvalho M; Moleta D; Tessariol Hachul D; Veronese P; Hardy C; Pisani C; Wu TC; Vieira MLC; de França LA; de Souza Freitas M; Rochitte CE; Bueno SC; Bastos Lovisi V; Krieger JE; Scanavacca M; da Costa Pereira A; da Costa Darrieux F
Circ Arrhythm Electrophysiol; 2023 Feb; 16(2):e011391. PubMed ID: 36720007
[TBL] [Abstract][Full Text] [Related]
35. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
[TBL] [Abstract][Full Text] [Related]
36. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
37. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
38. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
39. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update.
te Riele AS; Tandri H; Bluemke DA
J Cardiovasc Magn Reson; 2014 Jul; 16(1):50. PubMed ID: 25191878
[TBL] [Abstract][Full Text] [Related]
40. Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy.
Graziosi M; Ditaranto R; Rapezzi C; Pasquale F; Lovato L; Leone O; Parisi V; Potena L; Ferrara V; Minnucci M; Caponetti AG; Chiti C; Ferlini A; Gualandi F; Rossi C; Berardini A; Tini G; Bertini M; Ziacchi M; Biffi M; Galie N; Olivotto I; Biagini E
Open Heart; 2022 Apr; 9(1):. PubMed ID: 35444050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
